CONMED falls after Piper Sandler downgrades to 'neutral'

Conmed

17/03/2026 15:52

Updates

   ** Shares of medical technology company CONMED CNMD.N down 1.7% at $36.78

** Piper Sandler downgrades CNMD to "neutral" from "overweight" citing lack of near-term catalysts

** Says ongoing concerns around AirSeal performance and execution missteps have weighed on the stock for nearly two years

** Cuts PT to $39, which still implies an upside of 4.3% to stock's last close

** All six brokerages covering CNMD rate stock "hold"; median PT is $43 - LSEG data

** Including session's moves, CNMD down ~9.6% YTD

(Reporting by Prakhar Srivastava in Bengaluru)

((Prakhar.srivastava2@thomsonreuters.com))